Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: A hospital-based study

Cardiovascular Diabetology

Volumn 14, Issue 1, 2015, Pages

  Jung, Chan Hee ^a   Jung, Sang Hee ^b   Kim, Bo Yeon ^a   Kim, Chul Hee ^a   Kang, Sung Koo ^a   Mok, Ji Oh ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

^b CHA University   (South Korea)

Author keywords

Cardiac autonomic neuropathy; Omentin; Type 2 diabetes mellitus; Vascular complication

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; OMENTIN; ORAL ANTIDIABETIC AGENT; UNCLASSIFIED DRUG; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; CARDIAC AUTONOMIC NEUROPATHY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROTEIN BLOOD LEVEL; PULSE WAVE; SEX DIFFERENCE; AGED; ALBUMINURIA; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD; BLOOD PRESSURE; COMPLICATION; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; HEART RATE; OUTPATIENT DEPARTMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; STATISTICAL MODEL; URINE; VALSALVA MANEUVER;

AGED; ALBUMINURIA; ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD PRESSURE; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; GPI-LINKED PROTEINS; HEART RATE; HUMANS; LECTINS; LINEAR MODELS; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PERIPHERAL NERVOUS SYSTEM DISEASES; PULSE WAVE ANALYSIS; VALSALVA MANEUVER;

EID: 84944399615     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-015-0303-3     Document Type: Article

References (35)

1. Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. EurHeart J. 2013;34:2436-43.
2. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21:697-738.
3. Komiya T, Tanigawa Y, Hirohashi S. Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice. Biochem Biophys Res Commun. 1998;251:759-62.
4. Schaffler A, Neumeier M, Herfarth H, Furst A, Sholmerich J, Buchler C. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta. 2005;1732:96-102.
5. Tan BK, Pua S, Syed F, Lewandowski KC, O'Hare JP, Randeva HS. Decreased plasma omentin-1 levels in type 1 diabetes mellitus. Diabetes Med. 2008;25:1254-5.
6. Pan HY, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract. 2010;88:29-33.
7. Lapointe M, Poirier P, Martin J, Bastien M, Auclair A, Cianflone K. Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease. Cardiovasc Diabetol. 2014;13:124.
8. de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong DW, Shuldiner AR, Pollin TI, McLenithan JC. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007;56:1655-61.
9. Moreno-Navarrete JM, Catalan V, Ortega F, Gomez-Ambrosi J, Ricart W, Fruhbeck G, Fernandez-Real JM. Circulating omentin concentration increases after weight loss. Nutr Metab (Lond). 2010;7:27.
10. Shibata R, Ouchi N, Takahashi R, Terakura Y, Ohashi K, Ikeda N, Higuchi A, Terasaki H, Kihara S, Murohara T. Omentin as a novel biomarker of metabolic risk factors. Diabetol Metab Syndr. 2012;4:37.
11. Brunetti L, Leone S, Orlando G, Ferrante C, Recinella L, Chiavaroli A, Nisio CD, Shohreh R, Manippa F, Ricciuti A, Vacca M. Hypotensive effets of omentin-1 related to increased adiponectin and decreased interleukin-6 in intra-thoracic pericardial adipose tissue. Pharmacol Reports. 2014;66:991-5.
12. Sengul E, Duygulu G, Dindar S, Bunul F. Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease. Ren Fail. 2013;35:1089-93.
13. Yilmaz Y, Yonal O, Kurt R, Alahdab YO, Eren F, Ozdogan O, Celikel CA, Imeryuz N, Kalayci C, Avsar E. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand J Gastroenterol. 2011;46:91-7.
14. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003;26:1895-901.
15. Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev. 1994;10:339-83.
16. Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2005;48:164-71.
17. Freeman R. Diabetic autonomic neuropathy. Handb Clin Neurol. 2014;126:63-79.
18. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985;8:491-8.
19. Bellavere F, Bosello G, Fedele D, Cardone C, Ferri M. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed). 1983;287:61.
20. Moreno-Navarrete JM, Ortega F, Castro A, Sabater M, Ricart W, Fernandez-Real JM. Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity (Silver Spring). 2011;19:1552-9.
21. Narumi T, Watanabe T, Kadowaki S, Kinoshita D, Yokoyama M, Honda Y, Otaki Y, Nishiyama S, Takahashi H, Arimoto T, Shishido T, Miyamoto T, Kubota I. Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure. Cardiovasc Diabetol. 2014;13:84.
22. Tan BK, Adya R, Randeva HS. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med. 2010;20:143-8.
23. Zhong X, Zhang HY, Tan H, Zhou Y, Liu FL, Chen FQ, Shang DY. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin. 2011;32:873-8.
24. Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol. 2011;10:103.
25. Shibata R, Takahashi R, Kataoka Y, Ohashi K, Ikeda N, Kihara S, Murohara T, Ouchi N. Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men. Hypertens Res. 2011;34:1309-12.
26. Maser RE, Lenhard MJ. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab. 2005;90:5896-903.
27. Vinik AI, Maser RE, Ziegler D. Autonomic imbalance: prophet of doom or scope for hope? Diabet Med. 2011;28:643-51.
28. Jung CH, Kim BY, Kim CH, Kang SK, Jung SH, Mok JO. Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients. Cardiovasc Diabetol. 2012;11:24.
29. Prats-Puig A, Bassols J, Bargallo E, Mas-Parareda M, Ribot R, Soriano-Rodriguez P, Berengui A, Diaz M, de Zegher F, Ibanez L, Lopez-Bermejo A. Toward an early marker of metabolic dysfunction: omentin-1 in prepubertal children. Obesity (Silver Spring). 2011;19:1905-7.
30. Kilic DC, Oguz A, Uzunlulu M, Celik S, Koroglu G. Plasma omentin-1 levels are similar in nondiabetic metabolic syndrome patients and healthy subjects. J Endocrinol Metab. 2011;1:182-7.
31. Esteghamati A, Noshad S, Rabizadeh S, Ghavami M, Zandieh A, Nakhjavani M. Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: a randomized clinical trial. Regul Pept. 2013;182:1-6.
32. Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Lee KW, Nam MS, Park YS, Woo JT, Kim YS, Choi KM, Baik SH. Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus. Endocrine. 2013;44:680-7.
33. Mattace-Raso FUS, van der Gammen TJM, Knetsch AM, van den Meiracker AH, Schalekamp MADH, Hofman A, Witteman JCM. Arterial stiffness as the candidate underlying mechanism for postural blood pressure changes and orthostatic hypotension in older adults: the Rotterdam Study. J Hyperten. 2006;24:339-44.
34. Aso Y, Wakabayashi S, Terasawa T, Naruse R, Hara K, Takebayashi K, Inukai T. Elevation of serum high molecular weight adiponectin in patients with type 2 diabetes and orthostatic hypotension: association with arterial stiffness and hypercoagulability. Diabetes Med. 2012;29:80-7.
35. Hossein-nezhad A, Mirzaei K, Alatab S, Ahmadivand Z, Najmafshar A, Peppa M, Koliaki C, Dimitriadis G, Sivakumar T, Sivakumar S. Circulating omentin-1 in obesity and metabolic syndrome status compared to control subjects. Endocrinol Metab Syndr. 2012;S1:008.